accacc2022acc2023acc2024acuteaddressingadjuvantadvancedahaanalysisartarterialasco2021ashash2023ash2024asthmaatrialbasedbccbenefitbenefitsbetabetterbladderbloodbreakingbreastcancercarcinomacardiaccardiologycardiovascularcarecellchallengeschemotherapychest2024cholesterolchronicclinicalcllcombinationcontrolcontroversiescopdcoronarycovidcurrentdatadiabetesdiagnosisdiseasediseasesdosedrugsearlyeaseasd2022eaueffectefficacyehaeha2025ersers2024escesc2021esc2022esc2023esc2024eshesh2022esh2023esh2024esmoesmo2021esmo2023esmo2024eular2024eventsevidencefailurefibrillationfirstfocusfocusedfreefuturegallenglpguidelineguidelineshealthhearther2hfpefhighhighlightshrhypertensionimmuneimmunotherapyimpactimportanceimproveimprovesinfluenzainhibitorsinsightsinterviewisth2022iwlhjointkeynotekidneylandscapelargelateldlleukemialifelipidlongloweringlunglymphocyticlymphomamanagementmelanomametastaticmultiplemyeloidmyelomanavigatingnextnovelnoveltiesobesityoptionsoutcomesoverallpatientpatientspembrolizumabpeoplephaseplacebopluspositivepostpracticepressurepreventionprimaryprogressionprostatepulmonaryrandomizedrealreceptorrecurrencerefractoryrenalrespiratoryresultsriskrolesabcs2024safetyscreeningseveresglt2showssitcstandardstatestrategiesstudysurgerysurvivalsyndromestargetedtermtherapeutictherapiestherapytreattreatmenttrialtrialstripleupdateupdatesvaccinationvaccineversuswcclworldwvcdc